Neurocrine Biosciences Inc (NBIX)
Number of days of payables
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
Based on the provided data for Neurocrine Biosciences Inc, the number of days of payables is not available for the years December 31, 2020, 2021, 2022, 2023, and 2024. This lack of information on the number of days of payables makes it challenging to assess the company's efficiency in managing its accounts payable and its relationships with suppliers during these periods. Without this specific data, it is not possible to analyze the trend or make comparisons to industry benchmarks for this aspect of Neurocrine Biosciences Inc's financial performance.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
Neurocrine Biosciences Inc
NBIX
—
ADMA Biologics Inc
ADMA
33.77
Amgen Inc
AMGN
32.07
Bio-Techne Corp
TECH
14.14
Biogen Inc
BIIB
30.18
Gilead Sciences Inc
GILD
12.81
Halozyme Therapeutics Inc
HALO
10.25
Krystal Biotech Inc
KRYS
16.00
Moderna Inc
MRNA
25.08
Regenxbio Inc
RGNX
56.67
Repligen Corporation
RGEN
11.15